Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis

Heczey, A; Courtney, AN; Montalbano, A; Robinson, S; Liu, K; Li, MM; Ghatwai, N; Dakhova, O; Liu, B; Raveh-Sadka, T; Chauvin-Fleurence, CN; Xu, X; Ngai, H; Di Pierro, EJ; Savoldo, B; Dotti, G; Metelitsa, LS

Heczey, A; Metelitsa, LS (corresponding author), Baylor Coll Med, Texas Childrens Canc Ctr, Dept Pediat, Houston, TX 77030 USA.; Heczey, A; Metelitsa, LS (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.; Heczey, A; Metelitsa, LS (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.

NATURE MEDICINE, 2020; 26 (11): 1686

Abstract

V alpha 24-invariant natural killer T (NKT) cells have shown potent anti-tumor properties in murine tumor models and have been linked to favorable out......

Full Text Link